BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19697966)

  • 1. Cytokine antagonists for the treatment of asthma: progress to date.
    Antoniu SA
    BioDrugs; 2009; 23(4):241-51. PubMed ID: 19697966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine modulators as novel therapies for asthma.
    Barnes PJ
    Annu Rev Pharmacol Toxicol; 2002; 42():81-98. PubMed ID: 11807165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
    Maeda S; Yanagihara Y
    Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):37-42. PubMed ID: 22292562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5.
    Kips JC; Tournoy KG; Pauwels RA
    Eur Respir J; 2001 Mar; 17(3):499-506. PubMed ID: 11405532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines or their antagonists for the treatment of asthma.
    O'Byrne PM
    Chest; 2006 Jul; 130(1):244-50. PubMed ID: 16840409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on biologic-based therapy in asthma.
    Walsh GM
    Immunotherapy; 2013 Nov; 5(11):1255-64. PubMed ID: 24188679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging interleukin receptor antagonists for the treatment of asthma.
    Al Efraij K; FitzGerald JM
    Expert Opin Emerg Drugs; 2017 Sep; 22(3):275-283. PubMed ID: 28832218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-directed therapy in asthma.
    Ichinose M; Barnes PJ
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):263-9. PubMed ID: 15379594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL-4/-13 based therapy in asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):349-52. PubMed ID: 26021492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are cytokines responsible for the asthmatic state of the airways?
    Kips JC; Pauwels RA
    Monaldi Arch Chest Dis; 1996 Jun; 51(3):223-7. PubMed ID: 8766198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiallergic asthma properties of brazilin through inhibition of TH2 responses in T cells and in a murine model of asthma.
    Lee CC; Wang CN; Kang JJ; Liao JW; Chiang BL; Chen HC; Hu CM; Lin CD; Huang SH; Lai YT
    J Agric Food Chem; 2012 Sep; 60(37):9405-14. PubMed ID: 22920671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and cytokine-specific therapy in asthma.
    Desai D; Brightling C
    Adv Clin Chem; 2012; 57():57-97. PubMed ID: 22870587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursolic acid, a potential PPARĪ³ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
    Kim SH; Hong JH; Lee YC
    Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
    Barnes PJ
    J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What effect does asthma treatment have on airway remodeling? Current perspectives.
    Durrani SR; Viswanathan RK; Busse WW
    J Allergy Clin Immunol; 2011 Sep; 128(3):439-48; quiz 449-50. PubMed ID: 21752441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?
    Chung KF
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1320-6. PubMed ID: 14758771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geniposide inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma.
    Deng Y; Guan M; Xie X; Yang X; Xiang H; Li H; Zou L; Wei J; Wang D; Deng X
    Int Immunopharmacol; 2013 Nov; 17(3):561-7. PubMed ID: 23859870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies for the treatment of refractory asthma.
    Hambly N; Nair P
    Curr Opin Pulm Med; 2014 Jan; 20(1):87-94. PubMed ID: 24275927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.